Evidence map›Paper›PMID 15919941›Full record

ArticleJournal of virology2005

Involvement of the C-terminal disulfide-bonded loop of murine leukemia virus SU protein in a postbinding step critical for viral entry.

Michael D Burkhart, Paul D'Agostino, Samuel C Kayman, Abraham Pinter

Abstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Furin cleavage of the Moloney murine leukemia virus Env precursor reorganizes the spike structure.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael D BurkhartPublic Health Research Institute, 225 Warren Street, Newark, NJ 07103-3506, USA.
Paul D'Agostino
Samuel C Kayman
Abraham Pinter

Funding

ANTIGENIC PROPERTIES OF THE V1/V2 DOMAIN OF HIV-1 GP120R01AI046283 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PINTER, ABRAHAM · 2000 to 2010
$5.1M
Novel HIV Neutralizing Human MAbs from Transgenic MiceR01AI050452 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI PINTER, ABRAHAM · 2002 to 2006
$1.9M
Antigenic properties of the V1/V2 domain of HIV-1 gp120R56AI046283 · NIAID · PUBLIC HEALTH RESEARCH INSTITUTE · PI PINTER, ABRAHAM · 2005 to 2005
$493k
ANTIGENIC PROPERTIES OF THE V1/V2 DOMAIN OF HIV-1 GP120R21AI046283 · NIAID · PUBLIC HEALTH RESEARCH INSTITUTE · PI PINTER, ABRAHAM · 2000 to 2000
$111k
NIAID NIH HHS AI46283NIAID NIH HHS AI50452NIAID NIH HHS R01 AI046283NIAID NIH HHS R01 AI050452NIAID NIH HHS R21 AI046283NIAID NIH HHS R56 AI046283
6 · The paper itself

Abstract

A role for the C-terminal domain (CTD) of murine leukemia virus (MuLV) Env protein in viral fusion was indicated by the potent inhibition of MuLV-induced fusion, but not receptor binding, by two rat monoclonal antibodies (MAbs) specific for epitopes in the CTD. Although these two MAbs, 35/56 and 83A25, have very different patterns of reactivity with viral isolates, determinants of both epitopes were mapped to the last C-terminal disulfide-bonded loop of SU (loop 10), and residues in this loop responsible for the different specificities of these MAbs were identified. Both MAbs reacted with a minor fraction of a truncated SU fragment terminating four residues after loop 10, indicating that while the deleted C-terminal residues were not part of these epitopes, they promoted their formation. Neither MAb recognized the loop 10 region expressed in isolated form, suggesting that these epitopes were not completely localized within loop 10 but required additional sequences located N terminal to the loop. Direct support for a role for loop 10 in fusion was provided by the demonstration that Env mutants containing an extra serine or threonine residue between the second and third positions of the loop were highly attenuated for infectivity and defective in fusion assays, despite wild-type levels of expression, processing, and receptor binding. Other mutations at positions 1 to 3 of loop 10 inhibited processing of the gPr80 precursor protein or led to increased shedding of SU, suggesting that loop 10 also affects Env folding and the stability of the interaction between SU and TM.

Indexed as

Amino Acid SequenceAnimalsBinding SitesCell LineDisulfidesEpitope MappingHumansLeukemia Virus, MurineMiceMolecular Sequence DataMutationNIH 3T3 CellsProtein FoldingRatsViral Envelope ProteinsDisulfidesViral Envelope Proteins

Identifiers

PMID15919941
PMCPMC1143666
OpenAlexW2160387247

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.